SUBSCRIBE
SUBSCRIBE

Capricor Therapeutics

NEWS
Business
BioSpace Movers & Shakers: New Appointments for Maraganore, Afeyan
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
May 26, 2022
 · 
7 min read
 · 
Alex Keown
Drug Development
Capricor Ditches COVID-19 Vaccine Program to Focus on DMD
Capricor Therapeutics announced less-than-stellar Q4 2021 and full-year 2021 financial results and said the company stopped efforts on its COVID-19 vaccine.
March 11, 2022
 · 
2 min read
 · 
Hannah Chudleigh
Duchenne Muscular Dystrophy
Drug Development
New Capricor Data Signals Hope for Difficult-to-Treat Duchenne Muscular Dystrophy Population
Capricor announced positive final data from the HOPE-2 trial of its drug candidate. It showed a slowing of disease progression in Duchenne muscular dystrophy patients.
September 24, 2021
 · 
2 min read
 · 
Heather McKenzie
BioMidwest
Clinical Catch-Up: September 20-24
There was still some carryover from the European Society of Medical Oncology Congress 2021, but there was plenty of other clinical trial news last week. Here’s a look.
September 24, 2021
 · 
12 min read
 · 
Mark Terry
Genetown
Research Roundup: Getting the Inner Ear to Regenerate and More
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
August 5, 2021
 · 
5 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: August 26
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 26, 2020.
August 25, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: May 26
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 26, 2020.
May 26, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: April 29
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 29, 2020.
April 29, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: April 3
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 3, 2020.
April 3, 2020
 · 
6 min read
 · 
BioSpace Editorial Staff
Load More
JOBS
IN THE PRESS
Press Releases
Capricor Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 13, 2026
 · 
13 min read
Press Releases
Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12
May 4, 2026
 · 
4 min read
Press Releases
Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting
April 23, 2026
 · 
6 min read
Press Releases
Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
March 13, 2026
 · 
14 min read
Press Releases
Capricor Therapeutics Announces Late-Breaking HOPE-3 Data at the 2026 MDA Conference Demonstrating Significant Functional Benefits of Deramiocel for Duchenne Muscular Dystrophy
March 13, 2026
 · 
8 min read
Press Releases
Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA
March 10, 2026
 · 
6 min read
Press Releases
Capricor Therapeutics to Present Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Update on March 12
March 9, 2026
 · 
4 min read
Press Releases
Capricor Therapeutics Announces Late-Breaking Presentation at 2026 MDA Clinical and Scientific Conference
February 24, 2026
 · 
7 min read
Press Releases
Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar Highlighting Positive Phase 3 HOPE-3 Topline Results in Duchenne Muscular Dystrophy
December 17, 2025
 · 
4 min read
Press Releases
Capricor Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
December 5, 2025
 · 
5 min read
Load More